Compare PFG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFG | HOLX |
|---|---|---|
| Founded | 1879 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 16.6B |
| IPO Year | N/A | 1990 |
| Metric | PFG | HOLX |
|---|---|---|
| Price | $90.10 | $75.01 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 15 |
| Target Price | ★ $88.40 | $79.64 |
| AVG Volume (30 Days) | 1.2M | ★ 2.9M |
| Earning Date | 10-27-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.91 | 2.49 |
| Revenue | ★ $15,800,800,000.00 | $4,100,500,000.00 |
| Revenue This Year | N/A | $6.69 |
| Revenue Next Year | $8.78 | $5.74 |
| P/E Ratio | ★ $13.01 | $30.05 |
| Revenue Growth | ★ 12.33 | 1.74 |
| 52 Week Low | $68.39 | $51.90 |
| 52 Week High | $92.03 | $76.29 |
| Indicator | PFG | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.62 | 68.00 |
| Support Level | $85.71 | $74.77 |
| Resistance Level | $92.03 | $75.05 |
| Average True Range (ATR) | 1.71 | 0.30 |
| MACD | 0.55 | -0.14 |
| Stochastic Oscillator | 74.91 | 86.93 |
Principal Financial Group Inc is a financial services provider. It offers various financial products and services including retirement, asset management, and workplace benefits and protection solutions to individuals and institutional clients. The company, along with its subsidiaries, operates in the following reportable segments; Retirement and Income Solutions, Principal Asset Management, and Benefits and Protection. Maximum revenue is generated from the Retirement and Income Solutions segment which provides workplace savings and retirement solutions, banking, trust and custodial services, individual variable annuities (including RILAs), pension risk transfer, and investment services to businesses, their employees, and other individuals.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.